U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Delayed release oral dosage forms for treatment of intestinal disorders

Patent 5401512 Issued on March 28, 1995. Estimated Expiration Date: Icon_subject August 20, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
Patent #: 4250166
Issued on: 02/10/1981
Inventor: Maekawa ,   et al.

Drug units and methods for using same
Patent #: 5260071
Issued on: 11/09/1993
Inventor: Lemelson

Large intestinal dissociative hard capsules Patent #: 5283064
Issued on: 02/01/1994
Inventor: Suzuki, et al.

Inventors

Application

No. 107744 filed on 08/20/1993

US Classes:

424/458, Containing discrete coated particles pellets, granules, or beads424/461, Containing polysaccharide (e.g., cellulose sugars, etc.)424/462, Containing solid synthetic polymers424/463Coated capsules

Examiners

Primary: Page, Thurman K.
Assistant: Hulina, Amy

Attorney, Agent or Firm

Foreign Patent References

  • 0040590 EP. 11/13/1981
  • 0080341 EP. 06/13/1983
  • 0366621 EP. 05/13/1990
  • 0375063 EP. 06/13/1990
  • 0386967 EP. 09/13/1990
  • 3034929 JP. 02/13/1991
  • 2021407 GB. 12/13/1979
  • WO81/02671 WO. 10/13/1981
  • WO83/00435 WO. 02/13/1983

International Class

A61K 009/58

Foreign Application Priority Data

1991-02-22 GB

Abstract

An orally administrable pharmaceutical dosage form for selectively administering a drug to the intestine comprises a plurality of enteric coated granules of the drug contained in an enterically coated capsule which releases the granules in the small intestine. The granules are preferably coated with a coating which remains intact until the coated granules reach at least the ileum and thereafter provide a sustained release of the drug in the colon. Suitable coating materials are selected from the Eudragit range of (meth)acrylate and (meth)acrylic and polymers. The invention has particular application to topically active drugs such as topically active steroids, bismuth salts and complexes, and especially, 5-amino-salicylic acid.

Other References

  • Roth et al `hagers handbuch der pharmazeutischen praxis` 1971, Springer-verlag, Berlin Heidelbeerg New-York pp. 494-495, Nachbehandlungen von Gelatinkapsel
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?